
NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …

Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …

Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …

Novo Nordisk has moved to temporarily shut down two of its Phase 3 and one of its Phase 2 clinical …

AstraZeneca has pulled back the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage …

The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …

The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …

Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …

NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …

South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …

Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …

HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …

The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …

The UK government has come under fire from health experts and former cabinet ministers for its strategy in fighting the …

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …

A spokesperson from the Iranian foreign ministry has accused the US of refusing to deliver medicine to the country. US …